Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency

Marie-Elodie Cattin1, Anne T Bertrand, Saskia Schlossarek

  • 1Inserm, U974, Paris F-75013, France.

Insights

Heterozygous LMNA mutations in mice cause dilated cardiomyopathy (DCM) through two distinct phases involving lamin A/C levels and ubiquitin-proteasome system impairment, leading to heart failure.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Cellular Pathology

Background:

  • Dilated cardiomyopathy (DCM) is characterized by left ventricular (LV) enlargement and impaired systolic function, a leading cause of heart failure.
  • Mutations in the LMNA gene, encoding nuclear envelope proteins lamins A/C, are linked to DCM, often accompanied by conduction and rhythm abnormalities.
  • The precise molecular mechanisms connecting LMNA mutations to DCM pathogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the cardiac phenotype and underlying pathomechanisms in heterozygous Lmna(ΔK32/+) (Het) knock-in mice carrying a human LMNA mutation.
  • To elucidate the temporal changes in lamin A/C levels and the role of the ubiquitin-proteasome system (UPS) in disease progression.
  • To establish a relevant preclinical model for studying LMNA-associated DCM.

Main Methods:

  • Generation and characterization of heterozygous Lmna(ΔK32/+) knock-in mice.
  • Assessment of cardiac function, histology, and protein levels of lamin A/C.
  • Cross-breeding with Ub(G76V)-GFP reporter mice to evaluate UPS activity in the heart.
  • Functional assessment of engineered heart tissue with impaired UPS.

Main Results:

  • Het mice exhibited a cardiac-specific phenotype, developing DCM and mortality between 35 and 70 weeks of age.
  • Early-stage Het hearts showed reduced lamin A/C due to degradation of toxic mutant protein, likely causing remodeling via haploinsufficiency.
  • Late-stage Het hearts displayed normalized lamin A/C levels but increased toxic mutant protein, correlating with impaired UPS function and nuclear aggregation.
  • Heart-specific UPS impairment was identified in Het mice, contributing to cardiac dysfunction.

Conclusions:

  • Het mice represent the first heterozygous knock-in model demonstrating a cardiac-specific phenotype relevant to LMNA-associated DCM.
  • Cardiomyocytes in Het mice face a dual challenge: managing mutant lamin A/C degradation and compensating for lamin haploinsufficiency, both culminating in DCM.
  • These findings highlight the complex interplay between protein degradation pathways and nuclear envelope integrity in the pathogenesis of inherited cardiomyopathies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...